Quantcast

Latest Tumors Stories

2014-07-10 12:22:20

Fox Chase Cancer Center Study Finds that Some Women Do Better than Current Staging Guidelines Suggest New findings from Fox Chase Cancer Center paint a relatively optimistic picture of women’s chances of surviving a subset of breast cancers that have spread to the chest wall or skin, but not beyond. Tumors that grow into the skin, regardless of size and whether they have involved lymph nodes, are automatically classified as stage III – and called “locally advanced” tumors,...

Allergy Medications May Be The Next Class Of Cancer Fighting Drugs
2014-07-01 15:14:58

Rebekah Eliason for redOrbit.com – Your Universe Online In a surprising discovery, researchers have noticed that the same kinds of drugs that relieve watery eyes and runny noses from allergies can also help fight off tumors. This new report suggests that antihistamines could have significant anti-cancer properties. These types of drugs interfere with the cell function “myeloid derived suppressor cells” that is known to reduce the body’s ability to fight tumors. "This research is...

2014-06-18 23:13:01

PeptiMed, a biopharmaceutical company focused on novel mechanisms of drug delivery, is pleased to announce the allowance of its claims for a targeted elastin-like polypeptide (ELP) nanoparticle for delivery of nucleotide therapeutic agents. Madison, Wisconsin (PRWEB) June 18, 2014 PeptiMed announced today that it was awarded United States patent No. 8,680,045, entitled, “Compositions of a peptide targeting system for treating cancer.” The invention describes a protein nanoparticle...

2014-06-11 08:29:54

All 9 Out Of 9 Patients Who Have Reached 4 Injections Are Showing Tumor Cell Death, Tumor Shrinkage And/Or Stabilization Of Disease BETHESDA, Md., June 11, 2014 /PRNewswire/ -- Northwest Biotherapeutics (NASDAQ: NWBO) (NW Bio), a biotechnology company developing DCVax® personalized immune therapies for solid tumor cancers, announced today that, in the ongoing Phase I/II clinical trial of DCVax-Direct for all types of inoperable solid tumors, all 9 out of 9 patients who have...

2014-06-09 14:18:52

University of California - Santa Barbara A new platform developed at UCSB increases the efficiency of drug delivery and allows excess particles to be washed away Scientists at UC Santa Barbara have designed a nanoparticle that has a couple of unique — and important — properties. Spherical in shape and silver in composition, it is encased in a shell coated with a peptide that enables it to target tumor cells. What's more, the shell is etchable so those nanoparticles that don't hit...

2014-06-06 11:30:35

Rice University Rice, MD Anderson scientists refine technique for attacking hard-to-reach tumors Short, customized carbon nanotubes have the potential to deliver drugs to pancreatic cancer cells and destroy them from within, according to researchers at Rice University and the University of Texas MD Anderson Cancer Center. Pristine nanotubes produced through a new process developed at Rice can be modified to carry drugs to tumors through gaps in blood-vessel walls that larger...

2014-06-03 15:54:17

Rice University Animal tests show Rice-developed technology effective against aggressive cancer The first preclinical study of a new Rice University-developed anti-cancer technology found that a novel combination of existing clinical treatments can instantaneously detect and kill only cancer cells -- often by blowing them apart -- without harming surrounding normal organs. The research, which is available online this week Nature Medicine, reports that Rice's "quadrapeutics" technology...

2014-05-27 08:29:27

Initial Responses Seen Before Patients Have Completed Treatments; BETHESDA, Md., May 27, 2014 /PRNewswire/ -- Northwest Biotherapeutics (NASDAQ: NWBO) (NW Bio), a biotechnology company developing DCVax® personalized immune therapies for solid tumor cancers, today provided a summary of initial data to date in its ongoing Phase I/II clinical trial of DCVax-Direct for all types of inoperable solid tumors. The Company reported that over 50% of the patients who have completed at least half of...

2014-05-26 13:21:07

University of Texas M. D. Anderson Cancer Center Peptide antibodies hit immune-response-stifling MDSCs without harming other vital cells Scientists have found a way to target elusive cells that suppress immune response, depleting them with peptides that spare other important cells and shrink tumors in preclinical experiments, according to a paper published online by Nature Medicine. "We've known about these cells blocking immune response for a decade, but haven't been able to shut...

2014-05-26 13:14:18

University of California - San Diego Discovery may prove useful in future diagnoses and in developing new therapies Researchers at the University of California, San Diego School of Medicine have identified a mutated gene common to adenosquamous carcinoma (ASC) tumors – the first known unique molecular signature for this rare, but particularly virulent, form of pancreatic cancer. The findings are published in the May 25 advance online issue of Nature Medicine. Pancreatic cancer...


Word of the Day
bibliopole
  • A bookseller; now, especially, a dealer in rare and curious books.
This word comes from a Greek phrase meaning 'book seller.'
Related